Basra-INA
The Basra Investment Commission revealed today, Tuesday, the establishment of a pharmaceutical factory at a cost of 54 million dollars.
The head of the commission, Alaa Abdul-Hussein Salman, told the Iraqi News Agency (INA): "The Basra Investment Authority will allocate an area of (40) acres for the establishment of a pharmaceutical production plant, according to the planned location in the southwest of Basra Governorate, at a cost exceeding $ 54 million.
Salman added that "a local investor has been attracted in partnership with a Canadian investing company with distinguished experience in the field of medicines," noting that, "upon completion, the laboratory will produce about 60 types of various and multi-use medicines and treatments such as analgesics, anti-inflammatories, allergies, infections, and treating joints." "Diseases of the blood, diseases of the digestive system, diseases of the respiratory system, diseases of the heart and blood vessels, diseases of the nervous system."
Syria says several troops, civilians killed in alleged Israeli strike
1.9 quake - Eastern Mediterranean, Turkey, 74 km south of Fethiye
Japan to resume funding to UNRWA, following Sweden, Finland and Canada
Latin America, Caribbean set for record dengue season
Russia: The death toll from the shooting in Moscow has risen to 40 people
Three defendants who wanted to sell a child were arrested in Baghdad
Prime Minister will visit Washington on April 15